Exosomal MiR-205-5p Enhances Angiogenesis and Nasopharyngeal Carcinoma Metastasis by Targeting
Overview
Authors
Affiliations
The aim of this study was to investigate whether and how exosomal miR-205-5p regulated angiogenesis and nasopharyngeal carcinoma (NPC) metastasis. We found that up-regulated serum exosomal miR-205-5p levels were associated with NPC progression and worse overall survival of NPC patients. miR-205-5p over-expression significantly increased tube formation, wound healing, migration and invasion of NPC cells, and lung metastasis of NPC tumors, whereas miR-205-5p inhibition had opposite effects. Exosomal miR-205-5p from NPC cells promoted the migration, tube formation, and microvessel density (MVD) of HUVECs and . Furthermore, bioinformatics-, luciferase reporter-, and biotinylated miR-205-5p-based pull-down assays indicated that miR-205-5p directly bound to the 3' UTR of (). Exosomal miR-205-5p targeted to enhance the EGFR/ERK signaling and MMP2/MMP9 expression, promoting angiogenesis and NPC metastasis, which was abrogated by DSC2 over-expression. Finally, the levels of miR-205-5p transcripts were positively correlated with MVD but negatively with DSC2 expression in NPC tissues, and patients with miR-205/DSC2 NPC had worse overall survival. In conclusion, exosomal miR-205-5p promotes angiogenesis and NPC metastasis by targeting DSC2 to enhance EGFR/ERK signaling and MMP expression. This exosomal/miR-205-5p/EGFR/ERK axis may be a new therapeutic target for intervention of NPC metastasis.
Tan S, Li S, Xia L, Jiang X, Ren Z, Peng Q Int J Oncol. 2025; 66(3).
PMID: 39950321 PMC: 11844336. DOI: 10.3892/ijo.2025.5726.
Emerging roles of extracellular vesicles in oral and maxillofacial areas.
Wang Q, Sun J, Jiang H, Yu M Int J Oral Sci. 2025; 17(1):11.
PMID: 39900916 PMC: 11791077. DOI: 10.1038/s41368-024-00341-9.
Piccinno E, Schirizzi A, Scalavino V, De Leonardis G, Donghia R, Fantasia A Int J Mol Sci. 2025; 25(24.
PMID: 39769259 PMC: 11677161. DOI: 10.3390/ijms252413498.
Lazaridis A, Katifelis H, Kalampokas E, Lambropoulou D, Aravantinos G, Gazouli M Int J Mol Sci. 2024; 25(21).
PMID: 39519256 PMC: 11546551. DOI: 10.3390/ijms252111703.
Exosomal miRNAs: the tumor's trojan horse in selective metastasis.
Bayat M, Nahand J Mol Cancer. 2024; 23(1):167.
PMID: 39164756 PMC: 11334467. DOI: 10.1186/s12943-024-02081-0.